21.20.Z - Manufacture of medicines and other pharmaceutical products
26.70.Z - Manufacture of optical instruments and photographic equipment
28.29.Z - Manufacture of other general-purpose machinery notelsewhere classified
32.50.Z - Manufacture of medical and dental instruments and supplies
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.78.Z - Other retail sale of new goods in specialised stores
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
74.10.Z - Specialised design activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,6 | 0,5 | 0,4 | -22,3 |
Gross profit (loss) | 0,5 | 0,5 | 0,4 | -17,3 |
EBITDA | 0,5 | 0,5 | 0,4 | -15,5 |
Short time liabilities | 2,4 | 3,3 | 0 | -99,8 |
Other operating costs | 0 | 0,1 | 0 | -32,7 |
Equity capital | 1,6 | 0,5 | 0,6 | 7,8 |
Operating profit (EBIT) | 0,5 | 0,5 | 0,4 | -18,6 |
Assets | 4,1 | 3,8 | 3,7 | -3,2 |
Net profit (loss) | 0,5 | 0,5 | 0,4 | -23,1 |
Cash | 1 | 1,1 | 11,9 | |
Net income from sale | 3,4 | 3,9 | 4,8 | 23,4 |
Liabilities and provisions for liabilities | 2,5 | 3,3 | 3,1 | -4,9 |
Working assets | 4 | 3,1 | 2,9 | -6 |
Other income costs | 0 | 0 | 0 | 38,4 |
Depreciation | 0 | 0 | 0 | 1107,7 |
% | % | % | p.p. | |
Profitability of capital | 32,2 | 90,2 | 64,4 | -25,8 |
Equity capital to total assets | 39,7 | 13,4 | 15 | 1,6 |
Gross profit margin | 15,4 | 12,3 | 8,2 | -4,1 |
EBITDA Margin | 15,6 | 12,1 | 8,3 | -3,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 254 | 310 | 0 | -310 |
Current financial liquidity indicator | 1.6977499723434448 | 0.9496627449989319 | 574.7028198242188 | 573,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane